New Drug Shows Promise for Hard-to-Treat Ovarian Cancer
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read MoreAll content tagged with "folate receptor"
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read MoreScientists tested a new method to detect inflammation in the heart caused by the immune system attacking heart muscle. They used special tracers (like dyes …
Read MoreResearchers discovered that a new fluorescent dye called pafolacianine, which glows under special light, can help surgeons see cancer cells in children and …
Read MoreScientists have developed a new type of medicine designed to fight triple-negative breast cancer, a particularly aggressive form that's difficult to treat. The …
Read MoreScientists studying tadpoles discovered how thyroid hormone controls the complete rebuilding of the intestines during metamorphosis. They found that a specific …
Read MoreScientists have developed a new method to attach folic acid to other molecules in a more controlled and efficient way. Folic acid is a B vitamin that can help …
Read MoreScientists have figured out how to modify virus-like delivery vehicles to target cancer cells more accurately. They added folic acid (a B vitamin) to the …
Read MoreResearchers tested a new cancer-fighting drug called farletuzumab ecteribulin on 45 patients with ovarian cancer that had stopped responding to standard …
Read More